Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from its gene therapy program in transfusion-dependent beta-thalassemia at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition.
U.S. stocks traded mostly mixed, with the Dow Jones index gaining more than 100 points on Monday.
Here are some other big stocks recording losses in today’s session.
BMF-219 demonstrated early signs of clinical activity and ability to achieve durable and sustained complete responses (CRs) with minimal residual disease negativity (MRD-neg) in acute myeloid leukemia (AML)
Shares of Green Giant Inc. (NASDAQ: GGE) fell sharply in pre-market trading after announcing a proposed public offering.
Green Giant shares dipped 37.1% to $0.1599 in pre-market trading.
Here are some other stocks moving in pre-market trading.
Biomea Fusion, Inc. (“Biomea”) (NASDAQ:BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing novel covalent small molecules to treat and improve the lives of patients with